Evening – Inhaled insulin emerging as an option
The new approval for inhaled insulin provides a new treatment option for diabetics, especially children and teenagers aged six and above. This therapy relies on delivering insulin through the respiratory system instead of injections, allowing patients to inhale the dose quickly before meals without the need for injections. This reduces the burden of repeated injections and offers greater flexibility in their daily lives. Studies show that the effectiveness of inhaled insulin is comparable to rapid-acting injections, although some side effects like coughing may occur. It should be used with caution, particularly for individuals with asthma or chronic obstructive pulmonary disease (COPD), and a thorough medical assessment of lung function is necessary. This development does not mean the complete abandonment of injections but expands treatment options for effectively managing blood sugar levels. Regular medical follow-up is essential to determine its suitability for each patient.
Notice: This Is an AI-Generated Summary
Comments (0)